Denial Code 188: Product/Procedure Only Covered When Used Per FDA Recommendations

What it means

The payer denied this claim because the product or procedure was used in a way that falls outside FDA-approved or FDA-labeled guidelines. This often happens with off-label drug use, devices used outside their approved indication, or procedures performed in a manner not consistent with FDA clearance.

Common causes

Drug or biologic administered off-label without supporting payer policy documentation
Medical device used for an indication not covered by its FDA approval/clearance
Dosage, frequency, or route of administration outside FDA labeling
Missing or incomplete documentation showing medical necessity for off-label use
Procedure performed using investigational or non-FDA-approved protocol
Billing for a use still in clinical trial phase without appropriate coding/modifiers

How to fix it

Review the FDA label/indications for the specific product or procedure billed
Confirm the clinical documentation supports FDA-approved use, dosage, and route
If use was off-label, check payer's specific off-label coverage policy and required documentation (e.g., compendia support, peer-reviewed literature)
Resubmit with detailed clinical notes, medical necessity letter, and supporting literature if off-label use is covered under payer policy
Verify correct NDC, HCPCS, or CPT codes match the FDA-approved use
If billed in error, correct the code/indication and resubmit a corrected claim

Appeal / resubmit

When appealing, include the FDA label or package insert alongside clinical documentation that explains why the off-label or alternate use was medically necessary for this patient. Cite applicable compendia (e.g., NCCN, DrugDex) or peer-reviewed studies supporting the use if available, and reference the payer's own off-label coverage policy if one exists. Appeals are more likely to be reviewed favorably when supported by strong clinical rationale and documentation, though outcomes vary by payer.

Related codes

Frequently asked

Does this mean the claim will never be paid?

Not necessarily. If the off-label or alternate use is supported by strong clinical evidence and payer policy allows exceptions, the claim may be reconsidered on appeal with proper documentation.

What documentation helps most when appealing this denial?

FDA labeling, medical necessity letters, and references to clinical compendia or peer-reviewed studies supporting the specific use in question are typically most helpful.

Is this denial specific to drugs only?

No. It can apply to drugs, biologics, devices, and procedures where FDA approval or clearance defines the covered indication, dosage, or method of use.

More free billing tools: all denial codes · denial lookup · Medicare fee calculator

This content is for informational purposes only and does not constitute billing or legal advice. Coverage determinations depend on individual payer policies.